GGrantIndex
← Leaderboards

Loretta G Que

Duke University

$7,960,774
Attributed
$10,553,666
Total exposure
5
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.8M · FY200723
$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$11,911,849 · 6

By mechanism

R01$9,929,321 · 4
P01$1,358,183 · 1
K08$624,345 · 1

Top collaborators

Most similar at Duke University

Same institution · by research overlap

Others in their field

Top investigators on “Inflammation

Research focus

InflammationBronchodilator AgentsAsthmaEpithelial CellsNitric OxideProductionOxidative StressBronchoconstrictionMetabolismPathway InteractionsNitric Oxide SynthaseAsthmatic AirwayEnzymesMediatingCell Culture TechniquesAffectResponseAirway ObstructionAsthmaticBaseNovel TherapeuticsLiquid SubstanceArginaseEnzyme Activity

Grant awards (24)

Oxidative Stress and Regional Airway Remodeling and Fibrosis in Obese Asthma$737,246
R01 · FY2023 · HL · contact PI
SANDIA: Supplementing L-citrulline to overweight late Asthma oNset phenotypes to increase airway L-arginine/ADMA ratio and Improve Asthma control$700,666
R01 · FY2023 · HL
Oxidative Stress and Regional Airway Remodeling and Fibrosis in Obese Asthma$752,964
R01 · FY2022 · HL · contact PI
SANDIA: Supplementing L-citrulline to overweight late Asthma oNset phenotypes to increase airway L-arginine/ADMA ratio and Improve Asthma control$701,814
R01 · FY2022 · HL
Oxidative Stress and Regional Airway Remodeling and Fibrosis in Obese Asthma$746,515
R01 · FY2021 · HL · contact PI
SANDIA: Supplementing L-citrulline to overweight late Asthma oNset phenotypes to increase airway L-arginine/ADMA ratio and Improve Asthma control$702,231
R01 · FY2021 · HL
Oxidative Stress and Regional Airway Remodeling and Fibrosis in Obese Asthma$752,281
R01 · FY2020 · HL · contact PI
SANDIA: Supplementing L-citrulline to overweight late Asthma oNset phenotypes to increase airway L-arginine/ADMA ratio and Improve Asthma control$745,579
R01 · FY2020 · HL
SANDIA: Supplementing L-citrulline to overweight late Asthma oNset phenotypes to increase airway L-arginine/ADMA ratio and Improve Asthma control$779,232
R01 · FY2019 · HL
Modulation of Asthma by GSNO-based Therapies$392,500
R01 · FY2016 · HL · contact PI
Modulation of Asthma by GSNO-based Therapies$386,612
R01 · FY2015 · HL · contact PI
Modulation of Asthma by GSNO-based Therapies$384,650
R01 · FY2014 · HL · contact PI
SP-A as an immune modulator$1,358,183
P01 · FY2013 · AI · contact PI
Modulation of Asthma by GSNO-based Therapies$392,500
R01 · FY2013 · HL · contact PI
GSNO Reductase, S-Nitrosothiols, and Asthma$351,000
R01 · FY2011 · HL · contact PI
GSNO Reductase, S-Nitrosothiols, and Asthma$351,000
R01 · FY2010 · HL · contact PI
GSNO Reductase, S-Nitrosothiols, and Asthma$351,000
R01 · FY2009 · HL · contact PI
GSNO Reductase, S-Nitrosothiols, and Asthma$351,000
R01 · FY2008 · HL · contact PI
GSNO Reductase, S-Nitrosothiols, and Asthma$350,531
R01 · FY2007 · HL · contact PI
MODULATION OF NO WITH PULMONARY GENE TRANSFER$124,869
K08 · FY2004 · HL
MODULATION OF NO WITH PULMONARY GENE TRANSFER$124,869
K08 · FY2003 · HL
MODULATION OF NO WITH PULMONARY GENE TRANSFER$124,869
K08 · FY2002 · HL
MODULATION OF NO WITH PULMONARY GENE TRANSFER$124,869
K08 · FY2001 · HL
MODULATION OF NO WITH PULMONARY GENE TRANSFER$124,869
K08 · FY2000 · HL